Selank and semax: what the actual research says about these peptides

What did @stevieleaabberton actually say?

She tried selank five times and semax once, starting low and working up to what she described as 'a fairly large dose,' and her honest conclusion was: 'I feel like if you know, you know, and I'm just not.' She's publicly uncertain whether the issue is the supplier's product quality or her own physiology, and she's not naming the supplier until she can rule out a 'me problem.' That's actually a more careful position than most peptide content on TikTok takes.

She also mentions she's already placed a bulk order with her usual tested supplier, which suggests she's approaching this as a preliminary trial rather than a product endorsement. The confusion is genuine. She's not selling certainty here, and that's worth acknowledging before we get into what she got right and wrong.

Does the science back this up?

The idea that you should 'feel it immediately' with selank and semax has some basis in the literature, but it's more complicated than the biohacking community usually admits. Both peptides have short half-lives and central nervous system activity that can, in some studies, produce rapid anxiolytic or cognitive effects, but individual response variation is real and documented.

Selank is a synthetic analogue of tuftsin, a naturally occurring tetrapeptide. A 2008 study by Semenova et al. in the Bulletin of Experimental Biology and Medicine found anxiolytic effects in animal models at relatively low doses, but human data is thin and mostly from Russian clinical trials with methodological limitations. Semax, a synthetic ACTH fragment, has been studied for cognitive function and neuroprotection primarily in Russian research settings (Akhapkina and Akhapkin, 2013, Zhurnal Nevrologii i Psikhiatrii). Neither compound has completed large-scale Western randomised controlled trials. So when she says she doesn't feel a difference, that's entirely plausible, and not necessarily a quality problem.

What did they get wrong (or right)?

She gets credit for the supplier skepticism. Unregulated peptide markets have documented purity problems. A 2022 analysis published in JAMA Internal Medicine (Cohen et al.) found that a significant proportion of peptides purchased from research chemical suppliers did not match their labeled concentration. Her instinct to test before bulk-buying is sound consumer behavior in a poorly regulated space.

Where she's on shakier ground: the assumption that 'it should work straight away' is partly correct for some users but not a reliable diagnostic. Selank's anxiolytic profile may be subtle enough that people with low baseline anxiety don't register a noticeable shift. The fact that she 'feels calm' after her last dose is not nothing, but she may be expecting a subjective signal that doesn't match how these peptides actually work for people who aren't starting from a high-anxiety baseline. Also, the Easter show semax trial is genuinely confounded data, and she's right to flag that.

What should you actually know?

Selank and semax are not approved by the FDA or TGA for any therapeutic indication. They are not legal to prescribe or sell as medicines in most Western countries, and the research base supporting their use in humans is largely derived from Soviet-era and post-Soviet Russian literature, which carries real methodological concerns around blinding and reporting standards.

That doesn't mean they're inert. It means the dose-response relationship, individual variability, and safety profile in human populations are genuinely unknown by the standards of modern clinical evidence. If you're not feeling an effect, that could reflect poor product quality, your individual neurochemistry, an insufficient dose, or the real possibility that the effect size in healthy adults is smaller than anecdotal reports suggest. None of those possibilities can be ruled out from five intranasal administrations. Anyone considering these compounds should be doing so under medical supervision, not from a TikTok stack recommendation.